Enhanced casein kinase II activity in human tumour cell cultures  by Prowald, Katja et al.
Volume 176, number 2 FEBS 1954 October 1984 
Enhanced casein kinase II activity in human tumour cell 
cultures 
Katja Prowald, Hans Fischer* and Olaf-Georg Issinger+ 
Institut fiir Humangenetik, Universitiit a& Saarlades, D-6650 Homburg-J, and *Znstitut ftir Virusforschung, Deutsches 
Krebsforschungszentrum D-6900 Heidelberg, FRG 
Received 23 August 1984 
Casein kinase II (CKII) activity is enhanced as much as 2-3 fold in established and 4-5-fold in transformed 
human cell lines when compared to that of tibroblasts and primary human tumour cell cultures where CKII 
activity never exceeded a basic level. The high activity of CKII in transformed cells and in established cell 
lines was reduced to about the same basic level after treatment with heparin, a highly specific inhibitor of 
CKII activity. The activity of the CAMP-dependent protein k ase was virtually the same in fibroblasts and 
various human tumour cell lines investigated. 
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1. INTRODUCTION 
When a cancer is formed or a cell line estab- 
lished in vitro, the barrier of programmed senes- 
cence of cells must be overcome. A varied body of 
evidence indicates that protein kinases are involved 
in the path towards tumorigenicity [l-6]. 
Recent reports on elevated CAMP-independent 
protein kinase activity in leukaemic cells and solid 
glioblastoma compared to the corresponding con- 
trols, i.e., lymphocytes and brain tissue [7-g], 
prompted us to search for an increased CAMP- 
independent protein kinase activity in various 
tumour cell cultures and fibroblasts derived from 
the same patients. We focussed our attention on 
casein kinase II (CKII) since this enzyme has been 
shown to be involved in the phosphorylation of 
cellular compounds such as translational factors 
[lO,ll], glycogen synthetase [12-141 and the 
regulatory subunit of the R&Z protein kinase [15] 
in vivo and in vitro. Furthermore, CKII can be 
unambigously characterized even in crude cell 
lysates by its unique biochemical and biophysical 
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properties, i.e., (i) its elution profile on DEAE and 
phosphocellulose, (ii) its ability to utilize ATP and 
GTP in the phosphotransferase reaction, (iii) its 
sensitivity to heparin [16,17] and (iv) its substrate 
specificity for certain polypeptides of protein syn- 
thesis factors eIF-2 and eIF-3 [ 10, 11,171. Here we 
present evidence that CKII activity is enhanced in 
established and transformed human tumour cells 
when compared to that of fibroblasts and primary 
human tumour cell cultures. 
2. MATERIALS AND METHODS 
2.1. Biological material and cell culture 
Primary cell cultures (T25 18, T2496, men- 
ingiomas; T2565, glioblastoma; T2554, brain 
metastasis of an anaplastic carcinoma) were de- 
rived from biopsies immediately after removal 
from the patient and studied in early subcultures. 
Fibrosarcoma cell line I-IT-1080 is commercially 
available (Flow Lab.). The established and ex- 
perimentally transformed glioblastoma cell lines 
(T406, T508, HeRo) were derived from tumour 
biopsies and studied after 60 subcultures. 
Glioblastoma cell lines HeRo and HeRo-SV are 
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described in detail elsewhere [181. HeLa cells were 
from Dr K. Klihler, University of Stuttgart. 
Cells were grown in 25-cm’ Falcon flasks to a 
cell density of l-5 x 10’ cells in Ml99 medium sup- 
plemented with 10% newborn calf serum (NCS) or 
in MEM supplemented with 10% fetal calf serum 
(FCS). Details are given in the corresponding 
figure legends. 
2.2. Determination of casein kinase II activity 
Cells were isolated by trypsination, washed twice 
in phosphate-buffered saline (PBS) and were then 
suspended in extraction buffer (20 mM Tris-Cl- 
(pH 7.2), 100 mM NaCl, 100 PM EDTA, 7 mM 
2-mercaptoethanol, 10 PM PMSF). Cells were 
homogenized by applying 20 strokes with a tight 
fitting Dounce homogenizer. Nuclei were removed 
by centrifugation at 5000 x g for 10 min at 4’C. 
The postnuclear supernatant was used as an en- 
zyme source. The protein concentration of the 
cytoplasmic extracts was adjusted to 1 mg - ml-‘. 
5-~1 aliquots were used for the enzyme reaction. 
The enzyme mixture contained: 100 mM 
Mes-OH- (pH 6.9), 130 mM NaCl, 5 mM MgClz, 
0.5% casein (dephosphorylated), 10 mM DTT, 100 
FM ATP; the specific activity of the [y-“P]ATP 
was 500 cpm - pmol-‘. Total assay volume was 45 
~1. Incubation was at 37°C for 15 min. 30-~1 ali- 
quots were removed, spotted onto filter squares 
and precipitated with trichloroacetic acid. Filters 
were counted in a scintillation cocktail. 1 enzyme 
unit is defined as the transfer of 1 pmol 
phosphorus + min-’ - mg-’ protein at 37°C. 
CAMP-dependent protein kinase activity was 
determined as in [ 191. 
2.3. Immunojluorescen t staining 
Selected tissue cultures (meningioma, T2496; 
glioblastoma HeRo, transformed glioblastoma 
HeRo-SV) were grown on small slides in Falcon 
flasks. For staining, the slides were removed and 
washed 3 times in PBS. The cells were fixed in 
acetone at 4°C for 15 min. Slides were washed 
again twice in PBS and then a 0.2 ml IgG fraction 
from PAb (clone 412) mouse mouse hybridoma 
which specifically recognizes the large T-antigen 
was added. This was followed by an incubation at 
37°C for 30 min. After washing the cells 3 times 
with PBS, 0.2 ml FITCconjugated goat F(ab’)~ 
anti-mouse IgG-FITC (TAG), 1: 50 diluted, was 
480 
added. Staining was carried out at 37’C for 60 
min. To remove the fluoresceinated material, cells 
were washed again in PBS and finally embedded in 
PBS-glycerol. 
3. RESULTS AND DISCUSSION 
Primary cell cultures from benign or malign 
tumours degenerate generally after 10-15 passages; 
the reason for this phenomenon is still unknown. 
However, in a few cases primary cell lines become 
immortalized spontaneously and exhibit the typical 
features of an established cell line (e.g., higher pro- 
liferation rates and unlimited growth) [20]. 
Fig.1 shows growth curves of such a spon- 
taneously immortalized glioblastoma cell line, 
before and after transformation with SV40. We see 
that the SV40 transformed cells exhibit an approx. 
30% higher growth rate than the untransformed, 
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Fig.1. Growth curves of glioblastoma (T406) and 
transformed glioblastoma cells (T406-SV) under optimal 
conditions in MEM and in the presence of 10% fetal calf 
serum. 
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yet established counterparts. Furthermore, the 
transformed cell strains were free of infectious 
virus, grew to higher saturation densities and grew 
in soft agar. We investigated the CKII activity in 
all 3 types of cell culture, i.e., primary cell 
cultures, established and transformed cell lines, us- 
ing a variety of different human tumour cell 
cultures of different origin. 
Fig.ZA shows the CKII activity in primary tissue 
cultures from human tumour ceils and fibroblasts 
from the same patients. The enzyme activity varied 
between 200 and 500 U - mg-’ protein. Maximum 
observed differences between fibroblasts and 
primary human tumour cells from the same patient 
ranged from 15 to 30%. In contrast to the low 
CKII activities detected in primary tumour cell 
cultures the observed CKII activities were 
700-1000 U - mg-’ protein in established and 
1000-1600 U. mg-’ protein in transformed cell 
lines (fig.2B,C). With the exception of HeLa, all 
cells were transformed with SV40 (fig.2C). These 
data match well with reports on a CAMP- 
independent protein kinase activity in human 
leukaemic cells and solid glioblastomas which was 
usually twice that of the corresponding controls, 
i.e., lymphocytes and brain tissue [7-g]. The high 
1 
Fig.2. Casein kinase II activity in cytoplasmic extracts from (A) fibroblasts and human primary tumour cell cultures; 
(B) established cell lines and (C) transformed cell lines. Enzyme activity is expressed in units . mg-’ protein at 37°C: 
Tumour (T) fibroblast (F). Classification of the tumours is given in section 2. E indicates average enzyme activity from 
all fibroblasts investigated. Immunofluorescent staining of the large T-antigen in primary cell cultures [meningioma, 
T24% (D)], established [glioblastoma, HeRo (E)] and transformed cells [glioblastoma, HeRo-SV (F)]. 
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activity of CKII in transformed cells compared to antigen [21-261. The increase in CKII activity 
established cell lines was reduced to about the same seems acceptable in view of the observed stimula- 
basic level after heparin treatment and also ir- tion of cellular protein phosphorylation shown in 
respective of the kind of phorphoryl donor used in transformed cells [27-301 especially as CKII has 
the enzyme assay (fig.3A,B). If we were indeed been shown to phosphorylate stoichiometrically in- 
measuring different kinds of protein kinase ac- itiation factors of protein synthesis [lo, 111. Fur- 
tivities in established and transformed cell lines we thermore, it was shown that glycerate-2,3-Pz, 
would not expect this result. Hence, we consider which is involved in the regulation of the glycolytic 
these observations as strong evidence for a concept flux by modulating the activity of hexokinase and 
of gradual activation of CKII activity in the dif- phosphofructokinase, inhibits the phosphorylation 
ferent tissue cultures investigated which can be of the &subunit of initiation factor 2 (eIF-2) by 
shut off by a highly specific inhibitor. CKII [31]. 
CKII activity was enhanced in established and 
transformed cells; CAMP-dependent protein 
kinase activity was about 150 U - mg-’ protein in 
all cell lines investigated so far. 
Fig.ZD-F shows representative immunofluores- 
cent micrographs of cell lines which were analyzed 
for the presence of large T-antigen. Only virus- 
transformed cells (e.g., HeRo-SV, T408-SV, 
T506-SV and SVSO) gave a positive nuclear 
fluorescence as shown in fig.2F. As HeLa cells do 
not contain large T-antigen but still show CKII ac- 
tivity well in the range of SV40 transformed cells, 
we tend to believe that enhanced CKII activity 
reflects a secondary effect which is possibly caused 
by the establishment and transformation of the 
cells by another exogenous agent. This may be 
directly related to higher transcriptional and 
translational rates commonly found in tumour 
cells than, for instance, to the presence of large T- 
The relationship between the initiation of 
translation and glycolysis is intriguing, especially if 
one considers other observations where it was 
shown that most of the tumour cells are capable of 
extensive anaerobic glycolysis [32]. These observa- 
tions may turn out to be more apparent than real, 
as we still do not know whether CKII plays a 
specific or unspecific role in carcinogenesis and as 
other protein kinases are also present in tumour 
cells [l-6]. 
Although we do not yet understand the relation- 
ship between establishment function, transforma- 
tion and enhanced CKII activity, the observed dif- 
ferences in the activity of this particular enzyme in 
the human cell lines investigated make it an ideal 
marker to distinguish between primary cell cultures 
with a limited life-span and both established and 
transformed cell lines which have undergone 
immortalization. 
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Fig.3. Inhibition of CKII activity by heparin. CKII ac- 
tivity was tested in the presence of either ATP (A) or 
GTP (B). Solid columns show the CKII activity in the 
presence of 1 pg + ml-’ heparin. 
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